SymbolPKTX
NamePROTOKINETIX, INC.
SectorUNDEFINED
RegionNorth America
Industry-
Address44618 United States OH 109 W Main St
Telephone330-455-4971
Fax
Email
Websitehttp://www.protokinetix.com
IncorporationUS
Incorporated On1999
Employees
Fiscal Year12/31
Public Since
ExchangesOTC;NASDAQ
AuditorDavidson & Company LLP;
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001128189
Description

ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.

Additional info from OTC:
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever.

2025-12-23 18:12

New Form D/A - ProtoKinetix, Inc. Filed: 2025-12-23 AccNo: 0001128189-25-000008 Size: 6 KB

Read more
2025-11-25 14:12

A Letter from the CEO

Read more
2025-11-21 16:57

(99% Positive) ProtoKinetix, Incorporated (PKTX) Announces Clinical Development Update

Read more
2025-11-19 22:19

New Form 8-K/A - ProtoKinetix, Inc. Filed: 2025-11-19 AccNo: 0001079973-25-001802 Size: 209 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Read more
2025-11-17 19:56

ProtoKinetix Incorporated Mourns the Loss of President and Chief Executive Officer Clarence E. Smith; Appointment of Michael Guzzetta as His Successor

Read more
2025-11-17 13:36

(99% Neutral) ProtoKinetix, Incorporated (PKTX) Files Form 8-K

Read more
2025-10-10 20:58

(99% Neutral) ProtoKinetix, Incorporated (PKTX) Announces Regulatory Update

Read more
2025-10-02 14:43

New Form D - ProtoKinetix, Inc. Filed: 2025-10-02 AccNo: 0001128189-25-000007 Size: 7 KB

Read more
2025-09-15 21:00

New Form DEF 14A - ProtoKinetix, Inc. Filed: 2025-09-15 AccNo: 0001079973-25-001456 Size: 80 KB

Read more
2025-09-05 20:15

New Form PRE 14A - ProtoKinetix, Inc. Filed: 2025-09-05 AccNo: 0001079973-25-001430 Size: 78 KB

Read more